Inhibition of Lymphocyte Proliferation Stimulated by Lectins and Allogeneic Cells by Normal Plasma Lipoproteins

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1977 Dec 1

PMID 200701

Citations 22

Authors

J H Morse

L D Witte

D S Goodman

Affiliations

Soon will be listed here.

Abstract

Lipoproteins, isolated by sequential flotation at densities 1.006, 1.019, 1.063, and 1.21, were examined for their ability to inhibit human lymphocytes stimulated by allogeneic cells and by lectins (phytohemagglutinin-P and concanavalin A). All the classes of normal plasma lipoproteins inhibited lymphoproliferation when peripheral blood lymphocytes were cultured in autologous, heterologous, or lipoprotein-deficient plasma (d greater than 1.21). The rank order of inhibitory potency was intermediate density lipoprotein (IDL) greater than very low density lipoproteins (VLDL) greater than low density lipoproteins (LDL) greater than high density lipoproteins (HDL), regardless of the mode of stimulation. The concentrations of IDL, VLDL, and LDL required for complete inhibition of stimulated lymphoproliferation were considerably below the levels of each of these lipoproteins normally found in human plasma. In addition, the concentration of HDL required for 50-90% inhibition was in the range of HDL levels normally found in human plasma. Moreover, at relatively higher concentrations, lipoproteins suppressed the incorporation of [3H]thymidine into DNA below the levels seen with reseting, unstimulated lymphocytes. The results suggest that circulating lymphocytes may normally be highly suppressed by the combined effects of all the endogenous lipoproteins and that the lipoproteins may play important roles in vivo in modulating lymphocyte functions and responses.

Citing Articles

Skin γδ T cell inflammatory responses are hardwired in the thymus by oxysterol sensing via GPR183 and calibrated by dietary cholesterol.

Frascoli M, Ferraj E, Miu B, Malin J, Spidale N, Cowan J Immunity. 2023; 56(3):562-575.e6.

PMID: 36842431 PMC: 10306310. DOI: 10.1016/j.immuni.2023.01.025.

Regulation of Adaptive Immunity in Health and Disease by Cholesterol Metabolism.

Fessler M Curr Allergy Asthma Rep. 2015; 15(8):48.

PMID: 26149587 PMC: 4567252. DOI: 10.1007/s11882-015-0548-7.

Deficiency of scavenger receptor BI leads to impaired lymphocyte homeostasis and autoimmune disorders in mice.

Feng H, Guo L, Wang D, Gao H, Hou G, Zheng Z Arterioscler Thromb Vasc Biol. 2011; 31(11):2543-51.

PMID: 21836069 PMC: 3202973. DOI: 10.1161/ATVBAHA.111.234716.

The role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritis.

Zhang H, Wu J, Zhu J J Biomed Biotechnol. 2010; 2010:357412.

PMID: 20182542 PMC: 2825561. DOI: 10.1155/2010/357412.

Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro: two procoagulant activities are produced by peripheral blood mononuclear cells.

Schwartz B, Levy G, Curtiss L, Fair D, Edgington T J Clin Invest. 1981; 67(6):1650-8.

PMID: 7240413 PMC: 370740. DOI: 10.1172/jci110201.

References

Mowbray J . Ability of large doses of an alpha-2 plasma protein fraction to inhibit antibody production. Immunology. 1963; 6:217-25. PMC: 1423273. View

HAVEL R, EDER H, Bragdon J . The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955; 34(9):1345-53. PMC: 438705. DOI: 10.1172/JCI103182. View

LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View

Toyoshima S, Osawa T . Cholesterol inhibition of the temporary increase of membrane fluidity of lymphocytes induced by mitogenic lectins. Exp Cell Res. 1976; 102(2):438-41. DOI: 10.1016/0014-4827(76)90066-5. View

Curtiss L, DeHeer D, Edgington T . In vivo suppression of the primary immune response by a species of low density serum lipoprotein. J Immunol. 1977; 118(2):648-52. View

Ho Y, Brown S, Bilheimer D, Goldstein J . Regulation of low density lipoprotein receptor activity in freshly isolated human lymphocytes. J Clin Invest. 1976; 58(6):1465-74. PMC: 333319. DOI: 10.1172/JCI108603. View

Waddell C, TAUNTON O, TWOMEY J . Inhibition of lymphoproliferation by hyperlipoproteinemic plasma. J Clin Invest. 1976; 58(4):950-4. PMC: 333258. DOI: 10.1172/JCI108548. View

Schaffner W, Weissmann C . A rapid, sensitive, and specific method for the determination of protein in dilute solution. Anal Biochem. 1973; 56(2):502-14. DOI: 10.1016/0003-2697(73)90217-0. View

Burstein M, Scholnick H, Morfin R . Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res. 1970; 11(6):583-95. View

10.

Shinitzky M, Inbar M . Difference in microviscosity induced by different cholesterol levels in the surface membrane lipid layer of normal lymphocytes and malignant lymphoma cells. J Mol Biol. 1974; 85(4):603-15. DOI: 10.1016/0022-2836(74)90318-0. View

11.

NOBLE R, Campbell F . Improved accuracy in automated fluorometric determination of plasma triglycerides. Clin Chem. 1970; 16(3):166-70. View

12.

Burstein M, Scholnick H . Lipoprotein-polyanion-metal interactions. Adv Lipid Res. 1973; 11:67-108. View

13.

McConathy W, Alaupovic P . Studies on the interaction of concanavalin A with major density classes of human plasma lipoproteins. Evidence for the specific binding of lipoprotein B in its associated and free forms. FEBS Lett. 1974; 41(1):174-8. DOI: 10.1016/0014-5793(74)80981-6. View

14.

Girmann G, Pees H, Schwarze G, SCHEURLEN P . Immunosuppression by micromolecular fibrinogen degradation products in cancer. Nature. 1976; 259(5542):399-401. DOI: 10.1038/259399a0. View

15.

Jackson R, Morrisett J, Gotto Jr A . Lipoprotein structure and metabolism. Physiol Rev. 1976; 56(2):259-316. DOI: 10.1152/physrev.1976.56.2.259. View

16.

Eisenberg S, Levy R . Lipoprotein metabolism. Adv Lipid Res. 1975; 13:1-89. View

17.

COOPERBAND S, Nimberg R, Schmid K, Mannick J . Humoral immunosuppressive factors. Transplant Proc. 1976; 8(2):225-42. View

18.

Murgita R, TOMASI Jr T . Suppression of the immune response by alpha-fetoprotein on the primary and secondary antibody response. J Exp Med. 1975; 141(2):269-86. PMC: 2190533. DOI: 10.1084/jem.141.2.269. View

19.

Occhino J, Glasgow A, COOPERBAND S, Mannick J, Schmid K . Isolation of an immunosuppressive peptide fraction from human plasma. J Immunol. 1973; 110(3):685-94. View

20.

Benson M, Aldo-Benson M, Shirahama T, Borel Y, Cohen A . Suppression of in vitro antibody response by a serum factor (SAA) in experimentally induced amyloidosis. J Exp Med. 1975; 142(1):236-41. PMC: 2189878. DOI: 10.1084/jem.142.1.236. View